<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>TYZINE PEDIATRIC- tetrahydrozoline hydrochloride solution </strong><br><strong>TYZINE- tetrahydrozoline hydrochloride solution </strong><br>PharmaDerm  A division of Fougera Pharmaceuticals Inc.<br></p></div>
<h1>TYZINE<span class="Sup">®</span> NASAL SOLUTION</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="fougerapharminc20120326001"></a><a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-1"></a><p></p>
<h1></h1>
<p class="First"><span class="Bold">Rx Only</span></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-2"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First"><span class="Bold">Tyzine<span class="Sup">®</span></span> Nasal Solution contains tetrahydrozoline hydrochloride, 2-(1,2,3,4-Tetrahydro-1, naphthyl)-2-imidazoline monohydrochloride, as a nasal decongestant. The chemical structure is:</p>
<div class="Figure"><img alt="tyzine-image01.jpg" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=9bea4aec-219f-46a9-9af4-5baab2552073&amp;name=tyzine-image01.jpg"></div>
<p>Nasal Solution is available for topical nasal application as 0.1% nasal solution and as 0.05% pediatric nasal drops. The nasal solution is a solution of tetrahydrozoline hydrochloride in water, with sodium chloride, sodium citrate, edetate disodium, and benzalkonium chloride, with hydrochloric acid to adjust to the pH.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-3"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First"><span class="Bold">Tyzine<span class="Sup">®</span></span> Nasal Solution (tetrahydrozoline hydrochloride), a sympathomimetic amine, possesses vasoconstrictor and decongestant actions when applied to nasal mucosa, resulting in <span class="product-label-link" type="condition" conceptid="4137788" conceptname="Vascular constriction">vasoconstriction</span> of the smaller arterioles of the nasal passages. Information on the absorption, distribution and elimination of the drug is not available.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-4"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First"><span class="Bold">Tyzine<span class="Sup">®</span></span> Nasal Solution is indicated for decongestion of nasal and nasopharyngeal mucosa.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-5"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First"><span class="Bold">Tyzine<span class="Sup">®</span></span> Nasal Solution is contraindicated for patients who have shown previous <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to its components. The 0.1% solution is contraindicated in children under six years of age. <span class="Bold">Tyzine<span class="Sup">®</span></span> Nasal Solution is not to be used for infants under two years of age. <span class="Bold">Tyzine<span class="Sup">®</span></span> Pediatric Nasal Drops (0.05%) should be used for children between the ages of 2 and 6 years (See "<a href="#Dos-Admin">Dosage and Administration</a>"). <span class="Bold">Tyzine<span class="Sup">®</span></span> Nasal Solution should not be used by patients under treatment with Monoamine Oxidase (MAO) Inhibitors.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="section-6"></a><p></p>
<h1>WARNINGS</h1>
<p class="First"><span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">Overdose</span> in children may produce profound sedation. This may be accompanied by profuse <span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">sweating</span>, <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span> or even <span class="product-label-link" type="condition" conceptid="201965" conceptname="Shock">shock</span> (See "<a href="#Ovrdsg">Overdosage</a>").</p>
<div class="Section" data-sectionCode="42229-5">
<a name="section-6.1"></a><p></p>
<h2>General</h2>
<p class="First">Avoid doses greater or more frequent than those recommended below. Excessive dosage in children may, on rare occasions, cause severe <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>. Profuse <span class="product-label-link" type="condition" conceptid="138565" conceptname="Hyperhidrosis">sweating</span> may accompany this effect. Overdosage may also cause marked <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span> or even <span class="product-label-link" type="condition" conceptid="201965" conceptname="Shock">shock</span>. Use cautiously in patients with cardiovascular disease (e.g., <span class="product-label-link" type="condition" conceptid="317576" conceptname="Coronary arteriosclerosis">coronary artery disease</span>, <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span>), and metabolic-endocrine diseases (e.g., <span class="product-label-link" type="condition" conceptid="4142479" conceptname="Hyperthyroidism">hyperthyroidism</span>, <span class="product-label-link" type="condition" conceptid="201820" conceptname="Diabetes mellitus">diabetes</span>).</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="section-6.2"></a><p></p>
<h2>Information for Patients</h2>
<p class="First">Patients should be advised to follow the prescribed dosage regimen. The spray should be administered with the head held upright. To spray, squeeze bottle quickly and firmly and sniff briskly. Instillation of the nose drops can be most conveniently accomplished with the patient in the lateral head-low position.</p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="section-6.3"></a><p></p>
<h2>Drug Interactions</h2>
<table width="30%">
<col align="center" valign="top" width="50%">
<col align="center" valign="top" width="50%">
<thead><tr class="First Last">
<th align="center">DRUG</th>
<th align="center">EFFECT</th>
</tr></thead>
<tbody><tr class="First Last">
<td align="center">Monoamine Oxidase<br>(MAO) Inhibitors</td>
<td align="center"><span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">Hypertension</span></td>
</tr></tbody>
</table>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="section-6.4"></a><p></p>
<h2>Pregnancy</h2>
<div class="Section" data-sectionCode="34077-8">
<a name="section-6.4.1"></a><p></p>
<h3>Pregnancy Category C</h3>
<p class="First">Animal reproduction studies have not been conducted with <span class="Bold">Tyzine<span class="Sup">®</span></span>. It is also not known whether <span class="Bold">Tyzine<span class="Sup">®</span></span> Nasal Solution can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. <span class="Bold">Tyzine<span class="Sup">®</span></span> Nasal Solution should be given to a pregnant woman only if clearly needed.</p>
</div>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="section-6.5"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First">It is not known whether this drug is secreted in human milk. Because many drugs are secreted in human milk, caution should be exercised when <span class="Bold">Tyzine<span class="Sup">®</span></span> Nasal Solution is administered to a nursing woman.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-7"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First">Local application of <span class="Bold">Tyzine<span class="Sup">®</span></span> Nasal Solution can be associated with burning, <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">stinging</span>, <span class="product-label-link" type="condition" conceptid="4328356" conceptname="Sneezing">sneezing</span> or dryness of the mucosa. Occasionally, systemic sympathomimetic effects can occur, including <span class="product-label-link" type="condition" conceptid="378253" conceptname="Headache">headaches</span>, <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span>, <span class="product-label-link" type="condition" conceptid="437113" conceptname="Asthenia">weakness</span>, <span class="product-label-link" type="condition" conceptid="443782" conceptname="Tremor">tremors</span>, light-headedness, <span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">insomnia</span>, and <span class="product-label-link" type="condition" conceptid="315078" conceptname="Palpitations">palpitations</span>. Rebound congestion can also occur, and is characterized by chronic <span class="product-label-link" type="condition" conceptid="4275722" conceptname="Swelling">swelling</span> of the nasal mucosa resulting in chronic <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">redness</span>, <span class="product-label-link" type="condition" conceptid="4275722" conceptname="Swelling">swelling</span> and <span class="product-label-link" type="condition" conceptid="4320791" conceptname="Rhinitis">rhinitis</span>. If adverse reactions occur, discontinue use.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="Ovrdsg"></a><a name="section-8"></a><p></p>
<h1>OVERDOSAGE</h1>
<p class="First">The administration or ingestion of <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">overdoses</span> of <span class="Bold">Tyzine<span class="Sup">®</span></span> (tetrahydrozoline hydrochloride) Nasal Solution may result in oversedation in young children. <span class="product-label-link" type="condition" conceptid="4208104" conceptname="Drug overdose">Overdoses</span> have caused <span class="product-label-link" type="condition" conceptid="316866" conceptname="Hypertensive disorder">hypertension</span>, <span class="product-label-link" type="condition" conceptid="4169095" conceptname="Bradycardia">bradycardia</span>, <span class="product-label-link" type="condition" conceptid="4196193" conceptname="Drowsiness">drowsiness</span> and rebound <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span> in adults; a <span class="product-label-link" type="condition" conceptid="201965" conceptname="Shock">shock</span>-like syndrome with <span class="product-label-link" type="condition" conceptid="316447" conceptname="Chronic hypotension">hypotension</span> and <span class="product-label-link" type="condition" conceptid="4169095" conceptname="Bradycardia">bradycardia</span> may also occur. In either case, the treatment of overdosage is usually that of watchful expectancy and general supportive measures. The patient should be kept warm, fluid balance should be maintained orally, if possible, and parenterally, if necessary.</p>
<p>If the <span class="product-label-link" type="condition" conceptid="4313591" conceptname="Respiratory rate">respiratory rate</span> drops to 10 or below, the patient should be given oxygen, and respiration assisted. Blood pressure should be watched carefully to prevent a hypotensive crisis.</p>
<p>There is no known antidote for <span class="Bold">Tyzine<span class="Sup">®</span></span> Nasal Solution. The use of stimulants is contraindicated. To date, we have had no report of fatalities resulting from overdosages of <span class="Bold">Tyzine<span class="Sup">®</span></span> Nasal Solution and while the symptoms resulting from <span class="Bold">Tyzine<span class="Sup">®</span></span> Nasal Solution overdosage may be alarming, they are self-limiting and the patient recovers with no sequelae.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="Dos-Admin"></a><a name="section-9"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="section-9.1"></a><p></p>
<h2>Adults and Children 6 Years and Over</h2>
<div class="Section" data-sectionCode="42229-5">
<a name="section-9.1.1"></a><p></p>
<h3>Tyzine<span class="Sup">®</span> 0.1% Nasal Solution</h3>
<p class="First">It is recommended that 2 to 4 drops of <span class="Bold">Tyzine<span class="Sup">®</span></span> 0.1% Nasal Solution be instilled in each nostril as needed, never more often than every three hours. Less frequent administration is usually sufficient since relief is maintained for four hours or longer in most cases, and often for as long as eight hours. Bedtime instillation usually assures sleep undisturbed by the need for remedication before morning, or by <span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">insomnia</span> from central stimulation.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-9.1.2"></a><p></p>
<h3>Tyzine<span class="Sup">®</span> 0.1% Nasal Spray</h3>
<p class="First">It is recommended to squeeze quickly and firmly three or four times <span class="Bold">Tyzine<span class="Sup">®</span></span> 0.1% Nasal Spray in each nostril as needed, never more often than every three hours. Less frequent administration is usually sufficient since relief is maintained for four hours or longer in most cases, and often for as long as eight hours. Bedtime instillation usually assures sleep undisturbed by the need for remedication before morning, or by <span class="product-label-link" type="condition" conceptid="436962" conceptname="Insomnia">insomnia</span> from central stimulation.</p>
</div>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-9.2"></a><p></p>
<h2>Children 2 to 6 Years of Age</h2>
<div class="Section" data-sectionCode="42229-5">
<a name="section-9.2.1"></a><p></p>
<h3>Tyzine<span class="Sup">®</span> 0.05 % Pediatric Nasal Drops</h3>
<p class="First"><span class="Bold">Note: Do not use Tyzine<span class="Sup">®</span> 0.1% Nasal Solution or Tyzine<span class="Sup">®</span> 0.1% Nasal Spray</span></p>
<p>It is recommended that 2 to 3 drops of <span class="Bold">Tyzine<span class="Sup">®</span></span> 0.05% Pediatric Nasal Drops be instilled in each nostril as needed, and never more often than every three hours. Relief usually lasts for several hours, so that instillation is usually needed only every four to six hours. Instillation of nose drops can be most conveniently accomplished with the patient in the lateral head-low position.</p>
</div>
</div>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-10"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First"><span class="Bold">Tyzine<span class="Sup">®</span></span> Nasal Solution (0.1%) is available in:</p>
<p>30 mL bottles - NDC 10337-476-30<br>15 mL Nasal Spray Bottles- NDC 10337-476-15</p>
<p><span class="Bold">Tyzine<span class="Sup">®</span></span> Pediatric Nasal Drops (0.05%) is available in:</p>
<p>15 mL bottles - NDC 10337-477-15</p>
<div class="Section" data-sectionCode="44425-7">
<a name="section-10.1"></a><p></p>
<h2>Recommended Storage</h2>
<p class="First">Store below 86°F (30°C).</p>
</div>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-11"></a><p></p>
<h1></h1>
<p class="First"><span class="Bold">Rx Only</span></p>
<p>Manufactured for:</p>
<p><span class="Bold">PharmaDerm<span class="Sup">®</span><br>A division of Nycomed US Inc.</span></p>
<p>Melville, NY 11747 USA<br>www.pharmaderm.com</p>
<p>By Denison Pharmaceuticals, Inc.<br>Pawtucket, Rhode Island 02862</p>
<p>©Copyright 2000 Kenwood Therapeutics</p>
<p>IL062A</p>
<p>Rev. 06/11</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="fougerapharminc003"></a><a name="section-12"></a><p></p>
<h1>PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – 15mL Container</h1>
<p class="First"><span class="Bold">NDC 10337-477-15</span></p>
<p>Rx Only</p>
<p>PEDIATRIC NASAL DROPS</p>
<p>TYZINE<span class="Sup">®</span></p>
<p>(tetrahydrozoline hydrochloride)</p>
<p>0.05% SOLUTION</p>
<p>15 mL (1/2 FL. OZ.)</p>
<p>PharmaDerm<span class="Sup">®</span></p>
<div class="Figure">
<a name="f02"></a><img alt="PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – 15mL Container" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=9bea4aec-219f-46a9-9af4-5baab2552073&amp;name=tyzine-image02.jpg">
</div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="fougera201203333329002"></a><a name="section-13"></a><p></p>
<h1>PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – 15mL Carton</h1>
<p class="First"><span class="Bold">NDC 10337-477-15</span></p>
<p>Rx Only</p>
<p>PEDIATRIC NASAL DROPS</p>
<p>TYZINE<span class="Sup">®</span></p>
<p>(tetrahydrozoline hydrochloride)</p>
<p>0.05% SOLUTION</p>
<p>15 mL (1/2 FL. OZ.)</p>
<p>PharmaDerm<span class="Sup">®</span></p>
<div class="Figure">
<a name="f03"></a><img alt="PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – 15mL Carton" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=9bea4aec-219f-46a9-9af4-5baab2552073&amp;name=tyzine-image03.jpg">
</div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="fougerapharminc009"></a><a name="section-14"></a><p></p>
<h1>PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – 15mL Container</h1>
<p class="First"><span class="Bold">NDC 10337-476-15</span></p>
<p>Rx Only</p>
<p>NASAL SPRAY</p>
<p>TYZINE<span class="Sup">®</span></p>
<p>(tetrahydrozoline hydrochloride)</p>
<p>0.1% SOLUTION</p>
<p>15 mL (1/2 FL. OZ.)</p>
<p>PharmaDerm<span class="Sup">®</span></p>
<div class="Figure">
<a name="f07"></a><img alt="PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – 15mL Container" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=9bea4aec-219f-46a9-9af4-5baab2552073&amp;name=tyzine-image04.jpg">
</div>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="fougera201203333329003"></a><a name="section-15"></a><p></p>
<h1>PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – 15mL Carton</h1>
<p class="First"><span class="Bold">NDC 10337-476-15</span></p>
<p>Rx Only</p>
<p>NASAL SPRAY</p>
<p>TYZINE<span class="Sup">®</span></p>
<p>(tetrahydrozoline hydrochloride)</p>
<p>0.1% SOLUTION</p>
<p>15 mL (1/2 FL. OZ.)</p>
<p>PharmaDerm<span class="Sup">®</span></p>
<div class="Figure">
<a name="f04"></a><img alt="PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – 15mL Carton" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=9bea4aec-219f-46a9-9af4-5baab2552073&amp;name=tyzine-image05.jpg">
</div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>TYZINE PEDIATRIC 		
					</strong><br><span class="contentTableReg">tetrahydrozoline hydrochloride solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:10337-477</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">NASAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>TETRAHYDROZOLINE HYDROCHLORIDE</strong> (tetrahydrozoline) </td>
<td class="formItem">TETRAHYDROZOLINE HYDROCHLORIDE</td>
<td class="formItem">0.5 mg  in 1 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>sodium chloride</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>sodium citrate</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>edetate disodium</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>benzalkonium chloride</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>hydrochloric acid</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:10337-477-15</td>
<td class="formItem">15 mL in 1 BOTTLE, DROPPER</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA086576</td>
<td class="formItem">11/30/1979</td>
<td class="formItem">01/31/2017</td>
</tr>
</table></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>TYZINE 		
					</strong><br><span class="contentTableReg">tetrahydrozoline hydrochloride solution</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:10337-476</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">NASAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>TETRAHYDROZOLINE HYDROCHLORIDE</strong> (tetrahydrozoline) </td>
<td class="formItem">TETRAHYDROZOLINE HYDROCHLORIDE</td>
<td class="formItem">1 mg  in 1 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>sodium chloride</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>sodium citrate</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>edetate disodium</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>benzalkonium chloride</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>hydrochloric acid</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:10337-476-30</td>
<td class="formItem">30 mL in 1 BOTTLE, DROPPER</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<th scope="row" class="formItem">2</th>
<td class="formItem">NDC:10337-476-15</td>
<td class="formItem">15 mL in 1 BOTTLE, SPRAY</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA086576</td>
<td class="formItem">11/30/1979</td>
<td class="formItem">01/31/2017</td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>PharmaDerm  A division of Fougera Pharmaceuticals Inc.
							(043838424)
						</td></tr></table>
</div>
<p><div class="EffectiveDate">Revised: 9/2013<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>28a8f5ab-a540-4bd3-90c8-ce7a05c9dda9</div>
<div>Set id: 9bea4aec-219f-46a9-9af4-5baab2552073</div>
<div>Version: 2</div>
<div>Effective Time: 20130925</div>
</div>
</div> <div class="DistributorName">PharmaDerm  A division of Fougera Pharmaceuticals Inc.</div></p>
</body></html>
